Quality Data Services (QDS) is a United States-based Pharmaceutical startup that has been providing clinical management and monitoring, data management, safety management, biostatistical analysis, and medical writing services to the biopharmaceutical industry since its incorporation in 1995. With a track record of over 900 completed clinical trials and a flawless quality record, QDS has served a wide range of clients, from large international pharmaceutical companies to small virtual biotechnology firms. QDS takes pride in delivering unparalleled quality, consistently on time and within budget, leading to approximately 85% of their business coming from repeat customers. The startup's commitment to customer satisfaction has been a key driver of its success in the industry. Moreover, having conducted pivotal trials for over 100 compounds/devices and provided clinical services to 60 commercially available products, QDS has established itself as a reliable and efficient partner in clinical research and management for its clients. As of now, there is no public information available about the last investment or the investors involved with QDS. Nonetheless, the startup's consistent performance and strong reputation in the industry make it an attractive prospect for potential investors looking at opportunities in the pharmaceutical sector. With a focus on providing the best clinical service possible, QDS presents itself as a promising investment opportunity for venture capitalists seeking to tap into the pharmaceutical research and management market.
There is no investment information
No recent news or press coverage available for Quality Data Services, Inc..